# An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation.

- **DOI:** [10.3390/molecules25225474](https://doi.org/10.3390/molecules25225474)
- **Rating:** Sound (3.1 out of 5)
- **Verdict:** A broad, useful map of Nrf2–inflammation biology whose catalog-like synthesis stops short of resolving the field’s central contradictions.
- **Framework version:** v5.8
- **Pipeline version:** v0.4
- **Evaluation date:** 2026-08-18
- **Evaluation page:** https://www.nabu.science/paper/10.3390%2Fmolecules25225474

## Key claims

1. Nrf2 and its principal negative regulator, the E3 ligase adaptor Kelch-like ECH-associated protein 1 (Keap1), play a central role in the maintenance of intracellular redox homeostasis and regulation of inflammation
   - Support: Supported
   - Type: Primary finding
   - Basis: extensive mechanistic and preclinical literature supports the direction, though heterogeneous models and unreported source selection limit certainty
   - Location: Abstract
2. Nrf2 is proved to contribute to the regulation of the heme oxygenase-1 (HO-1) axis, which is a potent anti-inflammatory target
   - Support: Tentative
   - Type: Secondary
   - Basis: categorical wording exceeds a synthesis that acknowledges context dependence and unresolved molecular mechanisms
   - Location: Abstract
3. Nrf2 negatively controls the NF-κB signaling pathway by multiple mechanisms
   - Support: Supported
   - Type: Secondary
   - Basis: multiple cited mechanisms support the direction, while Section 3 documents important context-specific exceptions
   - Location: Section 3

## Strengths

- **Broad integration across inflammatory mechanisms** The review links Nrf2–Keap1 biochemistry with NF-κB, HO-1, cytokines, adhesion molecules, proteases, inflammasomes, and pharmacological modulators in a single narrative.
  - Dimension: contribution
  - Location: Sections 2–7
- **Contradictory evidence is directly acknowledged** Section 3 presents opposing findings on Nrf2 and NF-κB family expression, while Section 5 foregrounds evidence that Nrf2 can either suppress or support inflammasome activation.
  - Dimension: positioning
  - Location: Sections 3 and 5
- **Visible pathway from mechanism to therapeutics** Section 6 connects molecular mechanisms to approved DMF use and additional clinical-stage fumarate programs, making the translational pathway concrete.
  - Dimension: application pathway
  - Location: Section 6

## Limitations

- **No reported source-selection methodology** The article provides no databases, date range, inclusion criteria, or explanation of how its extensive literature was identified and selected.
  - Dimension: methodological rigour
  - Location: Absence of a Methods or search-strategy section
- **Contradictions catalogued rather than resolved** Sections 3 and 5 identify central contradictions but stop at describing them, without a framework for determining when Nrf2 enhances or suppresses inflammation.
  - Dimension: contribution
  - Location: Sections 3 and 5
- **Abstract language overstates mechanistic certainty** The Abstract calls the Nrf2–HO-1 relationship “proved,” while Sections 3–5 describe cell-specific effects, unresolved mechanisms, and controversial inflammasome findings.
  - Dimension: reporting
  - Location: Abstract; Sections 3, 4.1, and 5

## Reliability checks

Caveats (4 of 4 checks).

- **Internal coherence:** Noted. The central argument remains coherent, but the Abstract contains localized overstatement and the body has citation-format inconsistencies. These issues do not reverse the review’s main interpretation.
- **Research conduct:** Clean. As a narrative review presenting no original human or animal experiments, the article raises no applicable ethics, registration, data, or code conduct concern in the supplied text.
- **Reference integrity:** Clean. 268 of 268 checkable references verified
  - 268 references in manuscript
  - citation details diverge from the cited records for 1 reference
  - Citation details diverge for 1 reference:
    - #96 Rundlof A.K., Carlsten M., Arner E.S. The core promoter of human thioredoxin reductase 1: Cloning, transcriptional activity, and Oct-1, Sp1, and Sp3 binding reveal a housekeeping-type promoter for the AUrich element-regulated gene. J. Biol. Chem. 2004;276:30542–30551. doi: 10.1074/jbc.M101452200. (Differs from the cited DOI’s record on: year, title)
  - References not verified automatically are resolved manually within 24 hours.

## Post-publication record

- **Status:** Clean
- **Summary:** No retraction or expression of concern found in Crossref (includes Retraction Watch).
- **Last checked:** 2026-10-17
